Therefore, to experimentally compare the outcomes of ABHD11 inhibition to glutarate accumulation, we used HeLa cells as a well-studied cancer cell line, alongside primary human CD8+ T lymphocytes, where the effects of DEG have been well characterized9. Here, CD8A is linked to cancer.